| Also known as |
Luteinizing Hormone-Releasing Hormone (LHRH), Gonadotropin-Releasing Hormone (GnRH) |
| Blood pressure |
No significant effect |
| Chemical name |
Gonadorelin |
| Dosage (medical) |
Typically 100 mcg injected intravenously or subcutaneously |
| Dosage (sports) |
Not typically used for sports enhancement due to its specific hormonal effects |
| Effects |
Increases levels of LH and FSH, leading to stimulation of testosterone in men and ovulation in women |
| Formula |
C55H75N17O13 |
| Half-life |
2-10 minutes |
| Hepatotoxicity |
None reported |
| Lab Test |
Can influence LH and FSH levels in blood tests |
| Main action |
Stimulates the release of gonadotropins (LH and FSH) from the anterior pituitary gland |
| Side effects |
Headache, flushing, nausea, abdominal pain, injection site reactions |
| Storage conditions |
Store refrigerated at 2-8В°C |
| Substance class |
Peptide hormone |
| Trade name |
Factrel, Lutrelef |
| Use in sports |
Rare, mainly investigated for potential misuse in manipulating hormone levels in sports where hormone checks are implemented |
| Water Retention |
Minimal |
